US LNG exports surge but will buyers in China turn up?
Investing.com - Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares surged 15.9% on Thursday after the home care provider reported second-quarter earnings that far exceeded analyst expectations and significantly raised its full-year outlook.
The company posted adjusted earnings of $0.18 per share for the second quarter, substantially beating the analyst estimate of $0.04. Revenue reached $589.6 million, a 16.8% increase YoY and well above the consensus estimate of $533.92 million.
Net income nearly doubled to $27.0 million, representing a 94.3% increase from the same period last year.
"Our second quarter results reflect the continued positive momentum in all three operating divisions as we navigate the third year of our Strategic Transformation," said Jeff Shaner, Chief Executive Officer.
"The quarter was highlighted by revenue and adjusted EBITDA growth of 16.8% and 93.6%, respectively, when compared to the prior year period."
Adjusted EBITDA for the quarter was $88.4 million, or 15.0% of revenue, compared to $45.6 million, or 9.0% of revenue, in the second quarter of 2024. This represents a 93.6% increase YoY.
The company’s Pediatric Services (PDS) segment led growth with a $78.2 million increase in revenue, while Home Health and Hospice (HHH) and Medical (TASE:BLWV) Solutions (MS) segments added $5.5 million and $1.0 million in revenue growth, respectively.
Following the strong results, Aveanna raised its full-year 2025 guidance, now expecting revenue to exceed $2.3 billion, up from its previous forecast of over $2.15 billion and above the analyst consensus of $2.18 billion.
The company also increased its adjusted EBITDA guidance to more than $270 million, significantly higher than its previous outlook of over $207 million.
Matt Buckhalter, Chief Financial Officer, noted that the acquisition of Thrive Skilled Pediatric Care expands both the scale and capabilities of the company’s pediatric services, contributing to its improved outlook for the year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.